Alert detail
FDA Approval: SARCLISA (ISATUXIMAB) — Type 1 - New Molecular Entity
Policy ID: FDA-BLA761113Specialty: HematologyAdded: 7/1/2026Effective: 2020-03-02billing update
Full alert analysis requires a subscription
Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.